| 1 |
Gold JS,Dematteo RP.Combined surgical and molecular therapy:the gastrointestinal stromal tumor model.Ann Surg,2006,244(2):176-184.
|
| 2 |
Demetri GD,Benjamin RS,Blanke CD,et al.NCCN Task Force report:management of patients with gastrointestinal stromal tumor(GIST)-update of the NCCN clinical practice guidelines.J Natl Compr Canc Netw,2007,5(Suppl 2):S1-29;quiz S30.
|
| 3 |
Nishimura J,Nakajima K,Omori T,et al.Surgical strategy for gastric gastrointenstinal stromal tumors:laparoscopic vs.open resction.Surg Endosc,2007,21(6):875-878.
|
| 4 |
S.M.Choi, M.C.Kim, G.J.Jung, et al. Laparoscopic wedge resection for gastric GIST: Long-term follow-up results. Eur J Surg Oncol, 2007,33(4):444-447.
|
| 5 |
Hiki N, Yamamoto Y, Fukunaga T, et al. Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor dissection. Surg Endosc,2008,22(7):1729-1735.
|
| 6 |
Al-Batran SE, Hartmann JT, Heidel F, et al. Focal progression in patients with gastrointenstinal stromal tumors after initial response to imatinib mesylate:a three-center-based study of 38 patients.Gastric Cancer,2007,10(3):145-152.
|
| 7 |
DeMatteo RP,Maki RG,Singer S,et al.Results of Tyrosine Kinase Inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor.Annals of surgery.2007,245(3):347-352.
|
| 8 |
Gronchi A, Fiore M, Miselli F, et al. Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metaststic GIST.Ann Surg,2007,245(3):341-346.
|
| 9 |
Andtbacka RH,Ng CS,Scaife CL,et al.Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.Ann Surg Oncol,2007,14(1):14-24.
|
| 10 |
Hasegawa J,Kanda T,Hirota S,et al.Surgical interventions for focal progression of adcanced gastrointestinal stromal tumors during imatinib therapy.Int J Clin Oncol,2007,12(3):212-217.
|